Rebuilding Clinical Trials in the Image of Patient Need: Key Takeaways from Reuters Pharma Clinical 2021
Pharma Marketing Network
APRIL 30, 2021
Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. People of certain racial and ethnic backgrounds, including the Black and Latin American communities, are perhaps the most obvious.
Let's personalize your content